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objectives: The purpose of this work was evaluation of the course of the
disease; and its sequelae.
Methods: 364 patients were subjected to examination. They were hospita-
lized between 1993-1999 in Department of Neuroinfections and Parasitic
Diseases with diagnosis ofTBE. The diagnosis was based on epidemiologic
data clinical observations as well as examination of cerebrospinal 8uid and
serologic detection of antibodies against TBE virus in serum and CSF-elass
IgM and IgG (ELISA method with kits IMMUNOENZYM FSME IgM
and IgG by IMMUNO AG (Austria)
Results: In following ycars we hospitalized: 1993- 80 (21.98%). 1994- 70
(19.23%).1995- 49 (13.46%).1996- 54 (14.83%). 1997- 57 (15.66%). 1998-
44 (12.08%).1999-10 (2.75%) patients. The following clinical forms of the
disease were observed: Meningitis-145 (39.83%). Meningoencephalitis-l72
(47.25%). Encephalitis-23 (6.32%) and Meningoencephalomyelitis-16
(4.39%) patients. Among 28 (7.69%) patients coinfection with Borrelia
brugdorferi was stated. The sequelae after TBE were observed in 47
(12.91 %) patients: brachial plexy paresis-14 (29.79%), radiculitis-3
(6.38%), paresis of cranial nerves mostly n. VII u 8 (17.02%). hypoacusis-
3 (6.38%). synclroma cerebellaris-3 (6.38%), paraparesis-2 (4.25%), tetra-
paresis-l (2.13%) and hepatitis 7 (14.89%). pneumonia-3 (6.38%). endo-
carditis-2 (4.25%) and diabetes incipidus u 1 (2.13%). In analysed group of
patients there were no deaths.Conclusions Tick-Borne Encephalitis is viral
disease ofcentral nervous system often with severe course and sequelae wich
are connected not only with CNS but also with peripheral nervous system as
well as other systems and organs
IMo0341lWO cases of human rabies developed in spite of
postexposure prophylaxis
S. Ozer. O. Ak. N. Benzonana.1. Kuzu
KEAH Injectious Diseases and Clinical Microbiology Dept. Istanbul, Turkey
Two boys aged 11 and 13 years old were bitten by the same dog. In the first
case the lesion was in the frontoparietal region extending to the upper eyelid.
in the latter the lesion was below the lips. Both cases were subjected to
wound care without sutures; equine antirabies serum and human diploid cell
vaccine were administered followed by tetanus vaccination. Antibiotic
therapy was instituted and the patients were hospitalized so that vaccination
schedule could regularly be followed and the wounds treated. The semi-
owned unvaccinated dog died in the fifth day and was histopathologically
shown to be rabid. On the thirteenth day the first case ran temperature. He
presented signs ofencephalitis and died on the seventeenth day. The autopsy
led to the diagnosis ofrabies encephalitis. The other child remained healthy.
A ten year old girl was bitten by a stray dog in the frontoparietal region
and near the upper eyelid. She was subjected to wound care and one ofher
wounds was sutured. equine rabies immune globulin and human diploid cell
vaccine followed by tetanus vaccination and antibiotherapy was started. The
dog was killed and shown to be rabid. The vaccine schedule was followed
properly. On the 16th day she had aerophobia and hydrophobia and was
brought to our hospital. She died two days later and autopsy revealed rabies
encephalitis.
Rabies can still be a fatal disease despite proper postexposure prophylaxis
in cases which although very rarely the virus may have entered directly in to
the nervous system.
IMo03S1 Rotavirus encephalopathy: Pathogenetic
mechanisms reviewed
Paul N. Goldwater
Microbiology & Infectious Diseases Department, The Women's & Children's
Hospital, North Adelaide, Australia
Objectives: To review pathogenetic mechanisms of rotavirus encephalo-
pathy.
Methods: Literature review and findings obtained from two clinical cases.
Review: 2% of cases of rotavirus gastroenteritis exhibit neurological
symptoms and signs. Two recent cases ofrotavirus gastroenteritis associated
with neurological involvement - one with encephalitis (defined by abnormal
neurological signs, cerebrospinal 8uid (CSF) pleocytosis & detection of
rotavirus genomic RNA in the CSF [the rotavirus was serotype GIl) and
one with a non-in8ammatory encephalopathy (defined by abnormal neu-
rological signs. an entirely normal CSF & detection of rotavirus genomic
nucleic acid in the CSF [this totavirus was serotype G3)) serve as a basis to
explore potential pathogenetic mechanisms. Possibilities include direct vital
replication within neurones or indirect effects of the newly described
rotavirus "enterotoxin". The pathogenesis of rotavirus-associated encepha-
litis or encephalopathy has remained enigmatic, however. it is known that
rotavirus can indeed infect neuronal cells in vitro and in vivo and thus there is a
basis for a direct pathogenetic mechanism. The notion that gut-derived
toxins entering the blood stream from the rotavirus-damaged intestinal
mucosa is another possibility, but less plausible, as detection of bacterial
toxaemia in rotavirus diarrhoea cases has not. to my knowledge, been
reported. The novel claim that rotavirus non-structural protein 4 (NSP4) is
the first viral enterotoxin deserves further consideration in this regard, as it
seems that NSP4 is a strong secretory agonist mobilising intracellular
calcium. It is plausible that NSP4 or a peptide derivative could act either
directly through neuronal vital infection (supported by finding rotaviral
RNA in CSF) or indirectly through blood-borne delivery from the gut to
the brain.
Conclusion: In both clinical cases, rotavirus RNA was detected by RT-
PCR in CSF specimens. and suppom a direct effect ofThe virus on neuronal
cells.
P:2/1 - Hepatitis
IMoP42! Hemodynamics in patients with chronic viral
hepatitis Band C
I. V. Maev. N. D. Yushchouk. P. G. Filippov
Moscow State University ofMedicine and Dentistry, Moscow, Russian
Federation
Objectives: To investigate the peculiarities of the central hemodynamics,
portal hepatic circulation and microhemocirculation in patients with acute
and chronic viral hepatitis B and C.
Methods: We have observed 110 patients suffering from chronic viral
hepatitis (the average age was 39 + 1.7). among them 61.7% - men. and
38.3% women). Chronic hepatitis B (HCY) - in 30 patients, and 34 patients
had B + C (HB + CV). The hemodynamics condition was evaluated with
the help ofultrasonic scanning ofthe heart and vessels. Doppler bloodstream
investigation and radioisotope methods.
Results: The evaluation of the left cardiac divisions, undertaken on the
7th-10th day after the onset or exacerbation of the disease, revealed the
thickening ofthe left ventricular (LY) walls and its weight increase. In 31.1 %
ofpatients with HBS and 49% ofpatients with HCV the values oftheir final
diastolic (FDV) and final systolic (FSV) volumes of the left ventricle were
higher then a normal variation peak. A decrease in the output fraction (OF),
in the degree of shortening of the anterior-posterior LV dimensions (~S)
and in the speed of myocardial fiber circulatory shoncning (Vet) were
recorded. There was also recorded an increase in the cardiac index (Cl), best
expressed in ChHBC. A meaningful correlation was revealed between CI
and the bloodflow diameter and speed in the portal and splenic veins. In the
course of the microhemocirculation analysis of the patients with HCV and
HB + CV the changes were most well-expressed (53.3 and 76.5%). They
were a generalised arteriole spasm. changes in the arteriole shape, capillary
widening, and 52.9% of these patients had a decrease in lumen and
obturation of the capillary network. Arteriolo-venular shunts were
encounted in 21.7-41.2%.
Conclusion: The obtained results testify to severe hemodynamic abnorm-
alities in patients with acute and chronic viral hepatitis B and C.
IMoP43IHigh prevalence of HCV in thalassemic patients in
Shahr-E-Kord (Southwestern of Iran)
M. Avijegan, M. Bassirat Nia. S. M. K. Hosseini Asi. F. Heidarian
Peditric Ward of Shahr-E-Kord Uni. ofMed. Sciences, Shahr-E-Kord, Iran
Setting: HCV is the most common cause of post-transfusional hepatitis.
The thalassemic patients with multiple transfusion are at high risk of HCV
involvement and also mortality due to chronic HCV infection. Although
they are treatable with bone marrow transplantation.
Aim: TO determine the high prevalence HCV in thalassemic patients. and
to indicate that they are a rather major source of HCV.
Method and Material Anti-HCV and alanine transferase tests (ALT) carried
our on 113 thalassemic patients. To exclude false positive results in Anti-
HCV. all of the HCV positive sera controlled with Recombinant Immuno
Blot Assay (RIBA).
Results: HCV prevalence was 23%. The M:F ratio was 1/3:1. Most of the
posiTive cases aged more than 10 years old. whereas the negative cases aged
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IMoP4711ntrafamiliai spread of hepatitis Bvirus (HBV)
infection
IMoP46!lnterferon alpha-2a (Roferon-A) plus hepatitis B
recombinant vaccine therapy in the treatment of chronic
hepatitis Binfection
G. Usluer, H. CoIak, I. Ozgunes, E. Doyuk, N. Demirturk
Osmangazi University, Medical Faculty, Department ofInfectious Diseases.
Eskisehir, Turkey
Objectives: The aim of this study was to evaluate the response to Interferon
alpha-2a (Roferon A) plus Hepatitis B Recombinant Vaccine (Gen Hevac
B) in patients with chronic B hepatitis.
Methods: Eleven patients were studied. All ofthem were HBs Ag positive.
The diagnosis ofchronic hepatitis B was confirmed by the detection ofHBV
DNA (polymerasis chain reaction and hybridisation) and liver biopsy. HBe
Ag was negative in eight ofeleven patients. Patients were treated with IFN
alpha-2a at dosage 9 MU theree times a week for six months. Hepatitis B
recombinant vaccine (GenHevac B) were given theree doses (0-1-2.
months of therapy and 20 mg dose/im).
Results: At the end of6 month course oftreatment, elimination ofthe virus
(clearence ofHBV DNA) was found six ofeleven patients (% 50.9). HBe Ag
seroconversion was observed in all of three HBe Ag positive patients. There
isn't any serious adverse effects of high doses IFN therapy.
Conclusion: This was a preliminary study. We must investigate different
combination therapies with IFN in chronic HB.
Eliseo Minola, O. Fracassetti, F. Suter
Department of Infectious Diseases, Ospedali Riuniti, Bergamo, Italy
Objectives: Family clustering of HBV infection has been reported in the
endemic regions. Children and spouses ofHBV carriers frequently have an
increased prevalence of HBsAg positivity.
To determine the transmission ofhepatitis B virus (HBV) and to identity
other risk factors for HBV seropositivity in heterosexual couples. We have
investigated, in an open prospective trial, intrafarnilial infection ofHBV.
Materials and Methods: During September 1st, 1994. and June 3Oth,1999,
at Department ofInfectious Diseases, Bergamo, 147 HBsAg positive patients
(109 males, 74.1 %) were studied; 127 were HBeAgnegative (86.4%) and 20
HBeAg positive (13.6%) and these were investigated to evaluate the
intrafamilial transmission of HBV infection. Their age ranged from 21 to
66, with a mean age of 41.2 years. Anamnesis, particularly referring to a
previous history ofintravenous drug addiction (IVDU) or baemotransfusion
ofboth, patient and partner, was investigated. Then. a clinical evaluation of
serum levels of ALT and AST was performed; anti-HBV titer ofIgM was
determined by a enzyme immunoassay kit (Abbot Laboratories, North
Chicago, Illinois, USA), also was determined a HBV DNA by the
chemiluminescence procedure. These determinations were performed. for
all the patients, at the beginning of the study. All the patients (100%) have a
histologically proved chronic active hepatitis Band 15 out of 147 (10.2%)
with active cirrhosis. All sexual partners and children were investigated, to
check anti-HBV positivity.
Results: In the population of the study, only 27 patients out of147 (18.4%)
reported a HBV acute hepatitis at anamnesis. Risk factors were absent in 95
(64.6%) and present in 52 subjects (35.4%). Twenty-nine patients (19.7%)
previously are members of families with parents and/or brothers and sisters
HBsAg positive, blood transfusion were in 19 patients (12.9%) before 1980
and 4 have past or current heroin Lv. abuse; none were HIV positive. In all
147 partners (100%) were checked for HBsAg positivity and in 8 of them
(5.4%) were positive and 139 partners were negative (94.6%). Among these
8 HBsAg positive partners no one reported risk factors other than husband or
wife of HBsAg positive patients; all were partners of HBeAg negative
patients. Fifteen out of the 242 household siblings tested (6.2%) resulted
HBsAg positive, no one reported risk factors other than cohabitation with
HBsAg positive parent(s).
Statistical analysis: Fisher's exact test were used to assess the differences in
frequencies of the considered variables.
8/147 (5.4%)
5/38
3/109
P value (2 vs. 3, two-tailed Fisher's Exact Test) = 0.0276
1 HBsAg + ve partners
2 HBsAg +ve man ofHBsAg +ve women
3 HBsAg +ve wnmen ofHBsAg + ve man
Hev Ab prevalence among parttlers
mostly 5-9 years old. There was a significant difference berween age and
number of received blood units and ALT levels on one side and HCV
involvement on the other side. (P < °/°1, P < 0/004, P < °/0007
respectively)
Condusion: The prevalence rate of this study is between the prevalence
range mentioned in the textbook and some other studies. Also we found the
above-mentioned significant difference like previous studies.
KEYWORDS: HCV, Thalassemia, RlBA, ALT.
V. Skandami, A. Tsiringa, N. Alexandropoulos, E. Kandri, Z. Komninou
Microbiology Department of"Hippokration" General Hospital, Athens, Greece
Objectives: The aim of this work was to study the viral markers to Hepatitis
B in hemodialysis patients and the changes of these markers during a rwo
year period.
Material and Methods: Blood samples from 58 patients with chronic renal
failure treated in the Hemodialysis Unit ofour hospital, were tested for HBV
markers every six months during the period April 97-July 99. The markers
were determined by using micropracticles immunoassay (MEIA) test in an
IMX - Abbott analyser.
Results: Hepatitis B surface antigen (HbsAg) was detected in 4 (6.9%) ofthe
patients in their first sample. Anti-Hbe became negative in the second sample
for 2 of them. From the patients, 37 (63.8%) were positive for one or more
antibodies and 21 (36.2%) negative for all the markers. Anti-HBs in titer
higher than 10 lUll was detected in 27 (46.5%) patients, but an antibody titer
above 100 lUll was detected in 13 (22.4%) patients. Nine of them after
vaccination. Thirteen patients (22.4%) had positive the three markers anti-
HBs, anti-Hbe, anti-HBc, 3 (5.2%) had positive the two anti-HBs, anti-
HBc, 10 (17.2%) had anti-Hbe, anti-HBc and 11 (18.9%) had only one, the
anti-HBs. For 10 patients anti-Hbe became negative in the second or third
sample. No patient became HbsAg positive during the study period.
Conduslons: The 6.9% of the patients were HbsAg carriers. Protecting
antibodies in adequate titer (> 100 IUm were observed only in 22.4%.
Besides, 36.2% were negative for all the markers. So, a Hepatitis B vaccine is
recommended for all dialysis patients as exposure to hemodiaIy sis is a
significant risk factor for developing hepatitis B virus infection.
IMoP44 IA new aspect of the IgM immunoresponse to the
core antigen in chronic HBV (hepatitis Bvirus) infection
E. G. Lindenschmidt
Inst. Med. Microbiol., Univers. Hamburg, Hamburg, Germany
ObjtKtlve: Specific IgM class antibodies are commonly said to mark acute-
phase infection (e.g. Rubella, Toxoplasmosis). That this assumption is
wrong, had already been shown in latent and late latent syphilis 20 years
ago. As yet, the IgM immunoresponse to HBV core (lgM anti-HBc) in
chronic infection is not clearly understood. The only fact which has been
investigated is that IgM anti-HBc in this clinical case persists for at least 2
years (in contrast to acute infection, which is positive for 3-6 months). This
paper reports on IgM anti-HBc-follow-up studies to examine a new aspect
of this immunoresponse in chronic HBV infection.
Methods: The studies were performed with commercial ELISAs for
HBsAg and IgM anti-HBc. HBV-DNA was detected by rwo different
PCRs. Chronic hepatis B was screened serologically by positive HBsAg tests
for at least 2 years. Chronic pen;istent (CPH) and chronic active (CAH)
hepatitis B were distinguished by pathohistology.
Results: 3-6-months-follow-ups for IgM anti-HBc in 153 CPH and 181
CAH patients showed that in both groups IgM anti-HBc was cleaned after
2-6 years as detected after the onset ofinfection. About 20% ofCPH as well
as CAH patients persisted with IgM anti-HBc for at least 2 years. The course
of elimination of the IgM antibody does not differ statistically ("survival
analysis test") berween the two groups. It ist also significant that at the time
ofelimination ofIgM anti-HBc, in 98% ofcases HBV-DNA (this means also
core antigen) was detectable in sera. These data suggest that the IgM anti-
HBc immunoresponse in chronic hepatitis B is to be differentiated from so
far investigated kinds ofIgM response.
Conclusions: IgM anti-HBc is only applicable clinically for a calculation of
the age of chronic hepatitis B and not for the estimation of the outcome of
infection. In addition, IgM anti-HBc immunoresponse does not seem to be
involved in the immunopathogenesis of chronic HBV disease
IMoP4S1 Hepatits B virus markers in patients with chronic
renal failure treated with dialysis
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Conclusion: Acute phase of hepatitis B is associated with oxidative stress
presented by substantial depletion ofreduced glutathione, decreasing during
recovery with normalization of ALT activity.
during the follow-up was observed in 25 pts. (13.5%); however, the clinical
significance ofthis finding is unknown. HCV genotypes distribution seem to
correlate with the risk factor for acquiring HCV infection and does not
significantly differ from that observed in patients with chronic active
hepatitis and the same epidemiological pattern.
IMoP50I Reduced glutathione concentration in patients with
acute hepatitis type B
K. SWi~tek,J. juszczyk, E. WoZniak
Departmrnt of Infectious Diseases, University ofMedical Sciences in Poz""",
Poland
IMoP51! Antl-HCV reactivity dlerences in patients with
chronic hepatitis Cand In convalescents
P. Migdalski, J. juszczyk
Department of Infectious Diseases, Karol Marcinkowski University ofMedical
Sciences in Poznan, Poland
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IMoP49I Investigation of tissue types as risk factors In
progress of hepatitis Binfection
Z. Akcam, M. Sunbul, B. Durupinar, C. Eroglu, S. Esen, H.
Leblebicioglu
Ondokuz Mayis University School ofMedicine, Samsun, Turkey
Objective: Although most of acute hepatitis B virus (HBV) infection are
improved spontaneously 10 percent of them tend to continue as chronic
infection. Neonatal toler:mce:md genetic type are important mechanisms in
chronic persistancy. This study was aimed to investigate differences of tissue
:mtigens between patients who had chronic hepatitis and who gained natural
immunity after HBV infection.
Methods: Thirty patients who have natural immunity, 30 chronic active
hepatitis patients and 30 seronegative patients as control group were selected
r:mdomly for the study. 61 MHC Class-I antigens were studied by the
standard Terasaki microlymphocytotoxicity test and 20 MHC Class-ll series
by a polymerase chain reaction (PCR)- sequence specific primer (SSP)
technique.
Results: B8, CW6, CW7 antigens of Class-I and DRBl*03, DRBl*02
antigens of Class-II were statistically significant high in chronic active
hepatitis patients (p < 0.05 for BS, CW6, CW7 and DRBI*03; P < 0.01
for DQBl*02). All, B35, CW3, DRB1*13 and DRBl*16 were signifi-
cantly high in natural immune group (p < 0.05 for CW3, DRBl*13,
DRBl*16; P < 0.01 for All, B35). DQBl*05 was significantly higher in
natural immune and chronic active groups than the control group (p <
0.01). On the other hand DQBl*06 was higher in control group (p < 0.05).
COndusion: Patients who express tissue antigens which are convenient with
chronic persistancy could be closely followed after acute HBV infection.
GSH
ALT
Weeks
The aim of the study was to evaluate the changes of reduced glutathione
concentration (GSH) in patients with acute viral hepatitis type B.
Materials and methods: 30 adult patients (M = 11, F = 19, mean age x =
36.5 years old) with high ALT activity (mean value x = 1625 U/L), HBsAg-
positive were included. GSH concentration was determined in erythrocytes
with colorimetric method in the beginning of the acute phase and, after 2, 6
and 10 weeks, as well as ALT activity. 40 healthy adult subjects served as a
control group (normal range: 2.26-2.70 mmol/l er).
Results: In the first term a substantial depletion of GSH in all cases was
observed (x = 0.73 ± SD 0.47 mmolfl) with gradual increase after 2, 6 and
10 weeks (mean values respectively: 1.01 ± SD 0.46,1.85 ± SD 0.51 and
2.17 ± SD 0.29 mmolfl). During 10 weeks of observation there was high
negative correlation coefficient between GSH concentration and ALT
activity.
IMoP48ICourse of HCV Infection In a cohort of asymptomatic
vlremk patents
Conclusions: This study clearly demonstrates that intrafamilial spread of
HBV is prevalent in families and the carrier rate is higher than the overall
carrier rate of 2-3% in general population. These results underlines the
importance of a screening for HBsAg-positivity in all partners and in
household siblings of HBsAg positive family members, also in patients not
reporting other risk factors. Male members are at higer risk of HBsAg
positivity (P = 0.0276). HBsAg positivity was not related to a history of
addiction and with a history ofblood transfusion. In our study S partners of
147 were positive for HBV and among these none ofthem have a history of
addiction or a history ofblood transfusion. Also, in this high risk population,
it is extremely important to vaccinate the uninfected household members as
soon as a carrier is identified.
Eliseo Minola, O. Fracassetti, F. Suter
Departmrnt of Infectious Diseases, Ospedali Riuniti, Bergamo, Italy
Background: For many people infected with the Hepatitis C Virus (HCV),
the route of exposure, risk of transmission, and severity of associated liver
disease are unknown. The extent of serious complications in people,
asymptomatic and viremic, who have acquired chronic hepatitis C is
unclear. We studied these variables.
Methods: A cohort of185 patients (pts.) with Hepatitis C Virus infection,
detectable serum levels ofHCV RNA and normal aminotransferases serum
levels (ALT) for at least one year was retrospectivety evaluated in order to
determine epidemiological features and predictive parameters ofsubclinical
liver disease. We studied 185 patients (pts.) with chronic hepatitis C
infection, who were referred to our Centre between February 1986 and
june 1999. Other pts. were excluded because they had hemochromatosis, or
alcoholic liver disease. The pts. were also tested for HBsAg and anti-HIV by
enzyme-immunoassay (EIA); 6 pts. (3.2%) have co-infection with hepatitis
B virus and none was co-infected with HIV virus. Liver biopsies were
performed in 18 pts. (9.7%). The pts. who tested positive for HCV
antibodies on enzyme immunoassay and when anti-HCV was positive the
confirmation was obtained by recombinant immunoblotting assay (RIBA
III, Ortho Diagnostic System, USA). Hepatitis C virus RNA (HCV RNA)
was determined by reverse transcriptase polymerase chain reaction (RT-
PCR, Beckman Analytical). Different HCV genotypes were determined
(according to Simmonds classification) by the typing C kit (Beckman
Analytical, Milan, Italy). The evaluations also included a physical examina-
tion, serial determinations of alanine aminotransferase (ALT). Anti-HCV
testing 'Was also proposed to sexual contacts and fam.ily IDcrnbcn. Indications
for liver biopsy in this patients population are discussed.
Results: A totalof185pts. (144 females, 77.8%) were studied. The mean age
ofthe pts. was 41.0 years (range, 16 to 73) at the time ofour initial evaluation.
Possible source for HCV infection in 185 anti-HCV positive asimptomatic
pts. were: unknown = 85 (45.9%), past blood transfusion(s) = 74 (40.1 %),
past or current heroin i.v. abuse = 18 (9.7%), health care occupancy = 8
(4.3%). The mean duration of follow-up after presentation to us was 3.4
years (range, 1 to 9). Twenty-seven out of 147 sexual partners (18.4%)
studied were anti-HCV positive and possible source for HCV infection
were: unknown = 12, past blood transfusion(s) = 8, past or current heroin
i.v. abuse = 7 (2 concomitantly anti-HIV positive). Six (2.8%) out of the
211 household siblings tested resulted anti-HCV positive: one of them was
current i.v. heroin abusers and one have blood transfusion. Past acute
hepatitis was reported by a total of 7 pts. (3.8%). HCV RNA by PCR
were determined in all 185 pts. with normal ALT values (100%) and all were
positive. HCV genotyping, determined in 154 pts. (83.2%) revealed subtype
2 in 72 cases (46.8%), subtype Ib in 54 (35.1 %), subtype 3a in 7 (4.5%),
subtype la in 7 (4.5%), type 4 in 2 cases (1.3%) and indeterminate in 12 cases
(7.8%). Among 18 pts. positive for HCV RNA who underwent liver
biopsy, 13 had chronic persistent hepatitis,S had chronic active hepatitis and
none had cirrhosis. At enrolment mean values ofgamma-glutamiltranspep-
tidase serum levels were 23.9 U.I/l and offerritin serum levels were 68.8 ng/
ml. Mixed essential cryoglobulinemia were positive (cryocrit > 0.5%) in 6
out 30 pts. (20%). Only three patient was treated out of 185 pts. with
interferon at adequate dosages with long-term normalisation of the ALT in
two pts.
Conclusions: In a group of pts. seen at our referral Centre, the course of
hepatitis C virus infection in a cohort ofasymptomatic viremic patients was a
non progressive disease. Prevalent genotypes were, according to other
repotts, Ib and 2 (81.9%). The sexual partners studied were anti-HCV
positive in 18.4%. HCV-RNA spontaneous clear:mce from the serum
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The aim of the study was to analyse the anti-HCV reactivity in patients
suffering from chronic hepatitis C (CHC) and the convalescents.
Materialsancl methods: 20 patients (M = 13, F = 7, mean age x = 41.3 ±
8 years old) with the acute phase of the disease recorded 36-60 mo. ago and
with no symptoms of the disease during last 24 mo. or more were
investigated. All patients were HCV-RNA negative in serum with presence
of anti-Hey detected in EIA-test (Abbott III). 20 patients with chronic
hepatitis C (M = II, F = 9, mean age x = 42.6 ± 7 years old) anti-HCV
(EIA-test) and HCV-RNA (RT-PCR) positive, with histological confir-
mation, served as a comparative group. Additionally LIATEK HCV-3-test
(Organon-Teknika) in both groups was used. Results were analysed using
our own BLOT index (Bix) method. Reactivity against different antigens
estimated as .. + .. was presented as algebraic sum. Statistical analysis was
performed using t-Student's test (STATISTICA 5.1 '97 StatSoft SN: QP
7107853602G51).
Results: presented in Table 1.
Anti-HCV CI C2 E2/NSI NS3 NS4 NS5
Persistently
nonmJALT
levels and Persistently ALT normali-
ALTnor- HCV-RNA zation with ETR HCV-
malization negativity RNA (+) and negativiza-
and HCV- during 1-3 tion ofHCV-RNA in the
Time of Number of RNA nega- years follow next few months follow
assessing patients n tivity n (%) upn(%) upn(%)
ETR 78 16 (20.5%) 10(12%)
12 month 78 15(19%) 9(11.5%) 3 (RNA negativ)
24 month 49 12 (24.5%) 8(10%) 3 (RNA negativ)
J6 month 29 9(31%) 6(7.7%) 4 (RNA negative)
Conduslons: ETR response was observed in 16 pts. (20.5%), SR response
among them in 6 pts (7.7%); in to pts. (12.5%) with persistently normal
ALT levels, HCV-RNA was positive after discontinuation of treatment and
in the next I-3 years has disappeared.
Statistically significant dilfcrence
Conclusion: The quantitative and qualitative anti-HCV reactivity is low in
convalescents, intensive in patients suffering from CHC.
In patients with CHC anti-E2/NS1, anti-NS3 and anti-NS5 reactivity is
higher than in convalescents and the difference is statistically significant.
IMoPS31 Late virological response to the treatment of chronic
hepatitis C using Interferon alpha
B. Bolewska, J. Juszczyk
Dep. of Inf. Diseases, Univ. ofMed. Sciences, Poznan, Poland
ObJectIves: The aim ofthe study was to analyze biochemcal and virological
end oftreatment (ETR) and sustained response (SR) in patients with chronic
hepatits C treated with interferon alpha.
Methods: 78 adult patients (M-54, F-24, mean age -40.9 ± 8.0 years) with
abnormal ALT activity, anti-HCV- positive, HCV-RNA in serum positive
(by R T-PCR), histological evidence ofchronic hepatitis were included. All
patients were treated with interferon alpha-2b, subcutaneusly in the dose 5
MU three times a week for 6 months and followed for additional I-3 years
after treatment.
Results: are presented in the Table I below
IMoPS2! Viral hepatitis in westem Poland: Changing patterns
of hospitalized patients in the last decade (1990-1999)
J.Juszczyk
Department of Infectious Diseases, University School ofMedical Sciences in
Poznan, Poland
ObJectives: To analyse the proportions of hospitalized patients with viral
hepatitis and liver cirrhosis.
Methods: Patients hospitalized (decade: 1990-1999) in 87-bed hospital (in
average 1013 p./year) according to etiology ofacute & chronic hepatitis and
liver cirrhosis were assessed.
Results: 99.9% ofcases with symptomatic acute hepatitis were hospitalized.
The number ofpatients with hepatitis A was below 20, except years '95.-'96.
(58 & 42 cases); from 1.0% to 6.1 %/y. Continuous diminishing of percen-
tage of acure hepatitis B was observed: from 188 cases (17.4%) in '90. to 32
(3.4%) in '99. Incidence rate ofhepatits B in the region was diminished from
38/100,000 in '90. to 4.2/100,000 in '99. In this decade 6% oftotal population
of the region was vaccinated against HBV. The number and percentage of
acute hepatitis C non-characteristicaly Aucruated from min. 9 cases (0.8%) to
max. 23 cases (2.4%). The number & percentage of patients with chronic
hepatitis B&C and liver cirrhosis, rised, resp. from 4.7% in '90. to 25.4% in
'99, and from 50 (3.8%) in '90. to 148 (13.0%) in '99. Etiology of cirrhosis
was as follows: HCV-45%, HBV-15%, alcoholic-to%, HBV or HCV &
alcoholic 30%.
Conclusions: In the last decade the changes in proportion of hospitalized
patients were observed: acute hepatitis B diminished 3.4-times, chronic
hepatitis B&C rised 5-times and cirrhosis of the liver rised 3-times.
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IMoP54! Vertical transmission of HeY: Role of immunogenetic
factors
A. Maccabrunil , 1. Pacatil , E. Minola2, M. Asti3 , A. DeSilvestri4 , C.
Badulli3, M. Martinetti3
lInfectious Diseases Dept.; JImmunohematology Transfusion Cmur;
4Neonatology Dept.- IRCCS, University ofPavia; 2Infeaious Diseases Dept.-
Ospedali Riuniti Bergamo, Italy
Objectives: Mother-to-infant transmission ofHCV is now well established
and, although its incidence is low « 10%), represents the major cause of
pediatric HCV infection. Aim of this research is to evaluate the role of
infant's and mother's immunogenetic profile in inAuencing HCV vertical
transmission.
Methods: We enrolled 37 HCV-infected mothers followed up during
pregnancy and after delivery with their 46 babies at the Institute ofInfectious
Disease of the University of Pavia. 18 infants (10 females and 8 males),
resulted HCV-infected (steadly positive for HCV-antibody and HCV-
RNA over 20 months ofage). As a control group we used the 28 coetaneous
HCV-uninfected babies. All these children with their mothers underwent
genomic typing for HLA-DRBI, DQAl, DQBI polymorfism.
Results: Firstborn infants were more frequently infected (48.3% vs. 14.2%
p = 0.028). The persistence of HCV carriage seemed controlled by the
following conditions: I) maternal homozygosity at HLA-DRBllocus and
in particular at DR1386 residue 2) male infant positivity for HLA-
DRBI*1tOI (62.5% vs. 15% P = 0.012). On the contrary viral resistence
appeared controlled by: I) infant HLA-DQBI*0301 homozygosity 2)
mother HLA-DQBI* 0501 positivity 3) presence in the infant of the
HLA- Dr{3 sequence motif (Glu9, Ser13, Phe26, Tyr30, Va138, Tyr78,
HisSI, Val85, Val86) located in the HLA binding groove that we also found
characteristic of adult asymptomatic carriers.
Conduslons: In conclusion, our data suggest that immunogenetic factors,
together with birth order and child-sex, may play a role in infant's
susceptibility or resistence to HCV vertical transmission.
IMoPSS! Age trend of hepatitis Cvirus genotype distribution
in Belgium
A. 1. de Moreau de Gerbehaye, M. Bodeus, P. Goubau
Virology, Universiti Catholique de Louvain, HopitaISaint-Luc, Brussels,
Belgium
Objective: In Belgium, a variety ofHCV genotypes exists. We studied the
type distribution among age groups.
Methods: We analysed the genotype of SOl patients with chronic hepatitis
C. Genotypes were determined by INNO-LiPA (Innogenetics, Belgium).
Results: Ten patients had coinfection by several genotypes. Two hundred
seventyof491 (57%) had Ib, 66 (13.4%) 3a, 57 (11.6%) tao HCV subtype Ib
was the predominant subtype found in Belgium but its prevalence decreased
with time (76.5% ofpatients born in the twenties, 56.5% in the fifties, 39.3%
in the seventies) and the other genotypes increased in par allel (mainly la and
3a subtypes: 2.9% and 0% respectively in the twenties, 9.8% and 12% in the
fifties, 19.6% and 30.4% in the seventies). Patients with Ib genotype were
significantly older than those with other genotypes (P < 0.0001).
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Discussion: Three possibilities could explain the shift towards a wider
variety ofgenotypes in younger age. First. 1b could be the original subtype
in our country. while the others were imported at a later date. Second. the
non-lb subtypes could give a lower proportion of chronic carriers. which
would diminish their proportion over time. The first and the second
hypotheses could coexist. Third, the non-lb subtypes could have a higher
mortaliry. which seems improbable.
Condusion: The 1b genotype seems the oldest subtype in our country while
the others were imported later by the increase ofpopulation movements and
changing habits.
IMoP561 Quantitative branched DNA assay and genotyping
for HCV RNA in high risk groups of patients with Hepatitis C
M. Christofidou l • C. Lambropoulou-Karatzl, G. O. Dimitracopoulosl •
I. Spiliopoulou·
'Dept. Microb.; 2Dept Int. Med., Sch. Med.• Univ. ofParras, Patras, Gretce
Hepatitis C Virus (HCV) infection is common in various high risk groups.
The prevalence of anti-HCV. the distribution of HCV genotypes, the
correlation between genotype and viral load and the incidence ofcoinfection
ofditferent HCV strains in these groups, is the purpose ofthis study. MEIA 3
Abbott was used to screen sera for anti-HCV and lmmunoblot LlA 3
lnnogenetics to confirm anti-HCV positivity of 107 dialysis patients (DP),
63 intravenous drug users (IVDU), 200 hepatological patients (HP), 173
polytransfused patients with ,B-major thalassaemia (,B-MT) and also 307
blood donors (BD). HCV RNA was detected in sera by Amplicor R T PCR
(Roche). HCV genotyping was carried out by LiPA II Innogenetics. HCV
RNA was quantitated by bDNA 2 Chiron. Anti-HCV were found in 71 %
ofDP, in 95% ofIVDU, in 62% ofHP and in 53% of,B-TM. In BD only
2.6% had anti-HCV. HCV RNA was performed in sera with anti-HCV.
Genoryping ofHCV and detection of virus load were also carried out.
No. Vir. Load /
patients 13(%) Ib(%) 2a/2c(%) 3a(%) 4(%) mL
DP(65) 9 38 6 43 3 < 0.2-120
IVDV (33) 15 21 60 3 < 0.2-61
HP (105) 9 37 6 45 3 < 0.2-52
j3..TM (55) 14 18 It 29 27 < 0.2-21
BD(7) 15 42 15 28 < 0.2-7.5
In all above high risk groups the most prevalent genotype of HCV is 3a
followed by 1band la but in .B-TM group. 3a was followed by 4 and lb. In
BD the most frequent genorype is 1b followed by 3a. In all groups the
maximum viral load is correlated with genotype 3a. No one patient had
evidence of mixed HCV infection.
IMoP57ILack of ongoing immune escape in chronic hepatitis
and viral infections
M. N. Kantzanou. S. C. Hellier. F. Leschner, R. W. Chapman. P.
Klenerman
Nuffield Dept ofMedicine, john Radcliffe Hospital, Oxford. United Kingdom
Objectives: Hepatitis C virus (HCV) causes chronic infection in greater than
70% ofthose infected. The ability ofthe virus to persist in vivo results from a
balance between the host immune responses and the virus survival strategies.
In earlier studies using MHC Class I tetramers. our group has observed a
strong and broadly directed cytotoxic T lymphocyte (CTL) response in
patients with acute HCV while in those chronically infected the levels of
CTL are generally low and show a non-activated phenotype. We hypothe-
sized that CTL immune pressure may be responsible for the selection of
HCV variants that are able to escape CTL recognition or antagonise the
immune response. We therefore looked at HCV epitopes, to see ifwe could
observe variation over time.
Methods: Serum samples were collected from 5 patients at sequential visits
to the Hepatitis clinic in Oxford over a 2 year period. These patients aU had
CTL response< to HCV epitopes NS3 1073 or NS3 1406 as determined by
tetramer staining. Viral RNA was extracted and R T-PCR performed. The
PCR products were then cloned and sequenced.
Results: All 5 patients had mutations within the NS3 1073 epitope the
majority of which did not confer a change in the amino acid sequence. 2
patients had mutations that altered the amino acid sequence (CINGVCWSI
and CVNGVCWTV). The 3 p2tients who produced a CTL response against
NS3 1406 all had mutations that altered the amino acid sequence (KLVAM-
GINAV and KLVALGVNAV). However in all patients there was no
further variation over time in either epitopes.
Conclusion: Over the period of time that we observed these patients there
was no evidence of emergence of new escape variants due to immune
pressure from CTL. This is consistant with a lack of functional antiviral
activity of those CTL found in chronic disease.
IMoP5S1 Evaluation of HBsAg positive blood donors and
results of long-term follow-up
A. Mert, F. Tabak. R. Ouras, M. Bilir, R. Ozturk. H. Senturk. Y.
Aktuglu
Cerrahpasa Mrdical Faculty, University of Istanbul, Turkey
Objectives: To evaluate ofseveral features of HBsAg positive blood donon
and results of long-term follow-up.
Methods: A total of 480 adults who were fGund to be HBsAg positive
during screening of blood donors were included in this study.
Results: Sixty three ofth" donors (%13) were found to have high serum
transaminase levels at initial evaluation and additonal6 elevated during first 6
months and all these patients were accepted as chronic hepatitis. The
remaining 410 donors were followed as asymptomatic HBsAg carriers. Of
these carriers. there found HBeAg positivity in 5% (20/410), anti-HOY
positiviry in %2 (7/410), and anti-HCV positiviry in 1. HBV-DNA by PCR
positiviry was detected in 26% of the carriers studied (19/73). Of these 19
carriers. 58% (11/19) had HBeAg positivity and the remaining 42% had
anti-HBeAg positivity. One hundred twenty carriers were followed for an
average of24 months with 6 months intervals and HI (93%) had normal
transaminase level. Of the 9 patient with high transaminase level, 7 were
performed liver biopsy. It revealed minimal hepatitis in 2 and chronic
hepatitis in 5 cases. Nine ofthe 120 cases (%7.5) became HBsAg negative and
3 developed anti-HBs. No carriers developed hepatocellular carcinoma
during the follow-up period.
Condusion: It has been shown that 15% ofHBsAg( +) blood donon have
chronic hepatitis, and for asymptomatic carriers, spontaneous yearly HBsAg
c1earence is 1% and rate of developing chronic hepatitis is 4%. These
fmdings suggest that asymptomatic HBsAg carriers should be followed by
ALT and HBsAg yearly.
[MoP591 Viral hepatitis Cand BIn a group of HIV Infected
children
A. I. Ahmaida, I. M. Matoug. J. M. Obaidi
AI.Arab Medical University, Benghazi, Libya
Objectives: To highlight the difficulties determining the relative contribu-
tion of these two infections and the anti-retroviral therapy (ART) to the
clinical picture and liver damage.
Methods: The records of 161 patients with viral hepatitis and HlV were
studied. Features looked at included clinical findings, HIV viral load, Anti
HCV antibodies and HCV RNA viremia, HbsAg, AntiHBsAg and Anti
HBc, liver Dysfunction tests in addition to CD4 and CD8 COUDts.
Results: The age 95% confidence interval for age was 3.65-4.0 years. 86
were positive for HCV by Elisa. 58 out of86 were positive for HCV RNA in
plasma. 9 (5.5%) were positive for HBsAg and 25 were HBV immune. The
correlation between HCV count and age among patients for whom the
count was available was -0.58. Correlation between HCV load and ALT
was -0.3.
Conclusion: Liver dysfunction tests were abnormal because of multiple co-
existent reasons including HIV and hepatitis viruses in addition to possibility
of the confounding etfect of ART on the liver enzymes. Liver biopsies may
help in determining the etfect of the viral hepatitides on liver parenchyma
though not-necessarily its function.
IMoP60ISome observations regarding hepatitis C infection
S. Erscoiu. P. Calistru. G. Cosma. E. Ceausu. M. Cotiga
Clinic ofInfectious and Tropical Diseases Dr. V. Babes, Bucharest, Romania
Objectives: To estimate the prevalence ofhepatitis C (HCY) infection and
to appreciate the interferon-o and ribavirine treatment in patients hospita-
lized between 1997 and April 1999 in our clinic.
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Methods: Antibody anti-HCV and viral load were detected by second
generation ELISA test and by PCR. AiT and other markers of infection
were evaluated.
Results: HCV infection represented 2.5% ofall hepatitis hospitalized in our
clinic. Median age was 42 year old (range 14-83). The route of transmission
was unknown in most of cases (11 patients), 5 of them were infected by
blood transfusions. Median ALT value was 150 VI/I (range ISO-more then
1000). Viral loads were tested in 26 patients. Serotype I was detected in 4
patients. Number ofcopies was done in 13 patients (range 1500- > 600000
copies). Interferon a treatment received 6 patients and interferon a +
ribavirine treatment received 1 patient. After 9 months of treatment only
two patients registered low viral load (less then 100 times).
Conclusions: Hepatitis C emerged as a major public-health. Vntil now,
combination of interferon + ribavirine seems to be the most efficient
treatment in hepatitis C infection.
IMoP61 IMarkers of hepatitis Bvirus, hepatitis Cvirus and
hepatitis D virus infections in children with chronic hepatitis
Luminita Smaranda lancu'.2, Evelina Moraru', Stela Gotia l
IUniversity l!! Medicine and Pharmacy IllIi; 2Institute ofPublic Health IllIi.
Romania
Objective: to determine the prevalence ofhepatitis B virus (HBV), hepatitis
C virus (HCV) and hepatitis D virus (HDV) infections in children with
chronic hepatitis.
Methods: our srudy group consisted of 188 children with chronic active
hepatitis (CAH) (98) and chronic persistent hepatitis (CPH) (90). The
medium age was 9.6 age old with 108 male (57.44%) The HBsAg, anti-
HBc/total antibody (Ab), anti-HDVItotal Ab and anti-HCV total Ab were
tested by ELISA. Transaminases (AST, ALT) levels were also determined.
Results: HBsAg was detected in 120 patients (63%); 58 were CAH cases.
Anti-HBc/total Ab were present in 106 (94.64%) from a 112 tested children.
The prevalence ofHCV total Ab was in a selected group 67.3% (35 positive
children from a 52 tested patients) and 20% for anti-HOY total Ab (10/50).
ALT and AST were elevated: 5-6 fold and 3 fold bigger than the normal
accepted values in the patients with CAH and CPH respectively.
Conclusions: (1) The prevalence ofHBsAg was higher (63%) than in our
healthy population (13% in children from our region) (p < 0.001). (2) Even
the HCV infection is more frequent in adults, the prevalence of anti-HCV
total Ab was significantly higher (67.3%) than in other tested groups (16.4%
in children from orphanages). (3) The high prevalence ofanti-HDV total Ab
is smaller than other tested children with chronic hepatitis (60% respec-
tively). (4) The vaccination for HBV infection and the blood screening for
anti-HCV Ab will reduce the prevalence of these infections in our country.
IMoP62IThe hepatitis C is a general disease of human
N. I. Kouzntsovl , V.I. Rugal2
I Saint-Petersburg Medical Academy ofPostgaduale Sludies; 2Institute
Hematology Saint-Petersburg, Russian Federalion
Objective: Srudying bone marrow ofpatients with the hepatitis C. who do
not have change in blood cells.
Methods: We srudied bone marrow's trepanobyoptats of 25 patients
diagnosed to have hepatitis C. While examining the bone marrow samples
we used morphometric methods which provided us with the possibility to
access di1ferent stages of cell maturation. Also we examined clinical chem-
istry and serolory profiles of enrolled patients. PCR for HCV RNA was
performed on the patient's blood and bone marrow samples.
Results: The serological tests for AntiHCV-AB were positive in all patients.
They had undersized level ALT. Changes in bone marrow were found in all
patients. The distribution of haemopoesis was found to bear signes of
dismyelopoesis especially in erythroid and granulopoetic parts of medulla.
New and resting forms prevailed. We also found changes in hemopoietec
microenvironment. Tubuloreticular strucrures, cilindrical confronting cis-
ternes. multivesicular bodies and nuclear abnormalities were found in
reticular, endothelial and endosteal cells. PCR for HCV RNA in blood
was positive in all cases. Twenty patients out oftwenty-five initially enrolled
became PCR negative m blood after having a course: of treatment with IL-
113, however PCR still detected the presence of HCV RNA in bone
marrow.
Conclusions: The results received bear strong evidence ofdirect infection of
bone marrow cells by Hev. This research has indicated that the spectrum of
pathology in hepatitis C also includes several defects in bone marrow, even
m patients, who do not have changes of blood forming cells. Our research
supports the idea that hepatitis C is a general disease ofhuman.
IMoP63I Oinical, biochemical, and immunological
investigations on the outbreak of viral hepatitis type A during
October, November, December 1999 and January 2000
A. Petrov, N. Popivanova
Dept. of infectious diseases. Higher Medical Institute. Plovdiv. Bulgaria
Objectives: Viral hepatitis, including hepatitis A are still acrual problem of
infectious pathology. The aim of the present study is to analyse clinical and
biochemical results of patients with viral hepatitis type A during the
outbreak lasting four months - October, November, December1999 and
January 2000.
Methods: Very carefully are analysed clinical, biochemical and immuno-
logical investigations of all patients for this period - total 305 men and
women. Viral diagnosis is performed with reagent-kits from ABBOTT.
The monitoring is done dynamically, biochemical indexes ofliver function
(ALT, AST, BILL.) and cell-mediated immunity are followed by standard
methodology.
Results: From these 305 patients we found anti HAV IgM + in 293 patients,
HBsAg carriers + anti HAV IgM + - 11 patients, anti HCV + anti HAV
IgM + - 2 patients. All patients are distributed by sex, age and clinical form
of hepatitis. There is not fulminant hepatitis during this outbreak. Our
intention is to perform a monitoring ofall patients in periods not less than 3
months. The main interest is focused on the mixed forms ofviral hepatitis,
which are not so rare a phenomenon.
IMoP641 n virus at several populations from Spain
N. M. MartinC2, F. Garcia, M. Alvarez, P. Morata, M. C. Bernal, F.
GarciaJr., M. C. Marmo
Microbiology, I. Diseases and Nephrology Units, Universitary Hospital,
Granada, Spain
Objective: to evaluate the presence of TT virus, a newly described agent
with a possible implication in hepatitis, at risk and non-risk for parenteral
transmission populations of Southern Spain
Patients and methods: Samples tested were from: a) 100 control group; b)
70 HIV patients; c) 21 patients with chronic type C hepatitis; d) 20 patients
with chronic type B hepatitis; e) 25 patients with non A-non G hepatitis; and
/) 109 patients undergoing hemodialysis. TT virus DNA was tested on serum
samples by meanS ofan semi-nested PCR with previously described primers
annealing to the ORFI of the viral genome. Amplificate detection was by
2% agarose gel electrophoresis.
Results: TT virus DNA was detected as follows: 2% of the control group;
16% ofHlV patients; 33% ofchronic type C hepatitis; 20% chronic type B
hepatitis; 8% non A-non G hepatitis; and 16% ofhemodialysis patients. No
relation with epidemiological, virological or biochemical factors was
observed.
Conclusion: TT virus is present at the population from Southern Spain and
its detection is more frequent at those groups with a parenteral risk for the
acquisition ofinfectious diseases. In our series, there is no evidence ofrelation
between TT virus and biochemical evidence of hepatitis.
IMoP6S1 Detection of n virus genotypes
N. M. Martinez, C. AlvarC2, F. Garcia,]. A. Lorente, M. Alvarez, M. C.
Bernal, F. GarciaJr., M. C. Maroto
Microbiology & Legal Medicine Dept. Universitary Hospital, Granada, Spain
Objective: to srudy genotypic distribution ofTT virus (TTV) in Southern
Spain and to evaluate the ability of Restriction Fragment Length Poly-
morphism (RFLP) to detect them.
Patients and Methods: 37 amplificates of TTV DNA obtained through
seminested PCR from the ORFI were studied. For RFLP, amplificates
were digested with Pst I, Nde I, Nia III and Mse I during 4 h/37°C; digested
products were electrophoresed (pAGE) and silver stained. In II purified 2"
round products a direct sequencing was also performed with an ABI prism
310 Analyzer.
Results: using RFLP 10 isolates were genotyped as Gl, 5 as G2 and 6 were
mixed infections by GI + G2. Eight isolates were classified as Gl accom-
panied by an undetermined RFLP pattern, 3 as G2 and undetermined RFLPs
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and 5 were not typeable by this method. DNA sequencing was as follows: 3
G1,3 G2 and 5 were a mixture ofrelated DNA sequences; concordance with
RFLP was 100%.
Conduslon: using RFLP, Gl is the most prevalent in Southern Spain. A
high rate of mixed infections by more than one variant of TTV has been
observed among Spanish isolates. Though we have found a good concor-
dance between methods, previous DNA cloning should be performed.
IMoP66IJoint hepatitis A and hepatitis E infection - Clinical
implication
S. Anceva-Sami, L]. Ivanovski, V. Grunevska, D. Dimitriev, C.
Evtimova, M. Gaseva, K. Grozdanovski
Clillicfor I,ifectiou.< Diseases alld Febrile COllditions, Skopje, FYROM
Background: Hepatitis A (HA) is an endemic illness in Macedonia with
periodic epidemics. On the other hand, the participation ofacute hepatitis E
(HE) in nonA-nonC hepatitis docs not diverge from the prevalence expected
for our geographic distribution. Similar transmission was the reason for
examination ofthe possibility ofco-infection with HA and HE, as well as the
possible influence of HE upon the clinical progress ofHA.
Methods: A group of Il4 patients, among which acute HA diagnosed
clinically, in laboratory and serologically, were tested on the presence of
HEV-igM. The patients were monitored 2, 4, 6 weeks after the beginning of
the illness, and later each 2 months throughout a period of I year.
Results: Of the 84 sera tested on HA, the presence of HEV-lgM was
confirmed in 15 (17.8%) cases. The patients with co-infection were at an
age of11-31 years (21 in average), mostly from the broader city region. Five
(30%) of the patients with a combined infection were with an emphasized
icteric syndrome, in 20 of 69 (28.9%) patients with acute HA. The initial
level of aminotransferase in the two groups of patients was in average 20
times higher than the normal values. In 5 (5.9%) patients with a HA/HE
infection the illness lasted 8 weeks, while among the rest it ended within 4
weeks as monitored through the normalization of the aminotransferas
activity. No chronic sequels remained in any of the monitored patients.
Conclusion: Prevalence of HE among acute nonA-nonC hepatitis was
3.6%, yet its' participation along with HA indicates that the prevalence is
substantially greater. The warm climatic conditions, the lower hygienic
standard, the endemic maintenance ofHA create conditions for the presence
of HE in a larger percentage. The prolonged proceeding of the illness is a
result ofthe different incubation period ofboth illnesses. None ofthe patients
reported traveling into endemic regions, suggesting an autochthonous
infectiun.
IMoP67 1 Combination treatment of induction interferon alpha
and Ribavirin in HCV: A preliminary study
L. Krekulova, V. Rehak
Mulacs Hospital Pilsen; IV Dept. ofMedici"e, llItemal Medicine, MuIacs
Hospital, Prague 4, Czech Republic
Objectives: to assess the efficacy and tolerability of induction regimen of
interferon alpha in combination with Ribavirin in the treatment of chronic
hepatitis C in naive patients in comparison to standard regimen.
Methods: Combination therapy of chronic hepatitis C with interferon
alpha and Ribavirin is considered to be a standard treatment in the dosage
oD MU ofinterferon alpha 3 times weekly and 1000-1200 mg ofRibavirin
daily. End oftreatment response ofstandard dosing approximately 50% was
reported. We evaluated the induction regimen of interferon alpha in the
dosage of6 MU daily for the first 28 days, than tapered to 6 MU 3 times
weekly until the end ofmonth 3, followed with 3 MU 3 times weekly until
the end of month 12 together with Ribavirin 1000-1200 mg daily. We
treated group of 19 patients, 10 females, 9 males, mean age 29.5 years, PCR
HCV RNA positive. This group achieved 79% end oftreatment virological
response assessed by PCR. The overall tolerability was excellent, only one-
patient required temporary dose reduction of Ribavirin (5.3%) due to
hemoglobin drop. The mean maximal decrease of leukocyte count was 2.6
x 109/L, hemoglobin 2 giL and trombocytes 43 x 109/L. Sustained response
- virological status ofall patients 6 months after the end oftreatment is to be
further assessed.
Results: 79% of treated patients achieved end of treatment virological
response.
Results: Induction regimen of interferon in combination therapy with
Ribavirin proved to be more effective than standard regimen in terms of
virological response without an increase of adverse events.
IMoPAI Prevalence of hepatitis Cand G virus Infections
among intravenous drug users in CroatIa
Z. Trischler-Cekel , K. Seme2, M. Poljak2
'Hospital, Vukovar, Croatia; 2Medical Faculty, Ljubljana, Slovenia
Objectives: To determine the prevalence of hepatitis C virus (HCY) and
hepatitis G virus (HGV) among intravenous drug users (IVDUs) in Croatia
(we have conducted a study on 102 Croatian IVDUs from state capital).
Methods: The prevalence ofHCV and HGV infectiom was assessed by the
detection of both antiviral antiboclies and viral genomes in serum samples.
Results: HCV and HGV infections were detected in 70 (68.6%) and 39
(38.2%) Croatian IVOUs. HCV positive Croatian IVOUs were signifi-
cantly older and reported longer duration of intravenous drug use in
comparison with HCV negative IVDUs. In contrast, no significant differ-
ences in both parameters were found among HGV positive and HGV
negative IVDUs.
Conclusions: The established prevalence ofboth HCV and HGV infections
in Croatian IVOUs are lower in comparison with those found among
IVOUs from the majority of other European countries.
P:2/2 - Herpes virus infections
IMoP691 Cytomegalovirus Infection and atherogenesis
A. Szkaradkiewicz,]. Bogaczytlska-Staniewicz, L. Torlliiski, M. Wal
Karol Marcinkowski University ofMedical Sciences itt Poztu/n, Poltmd
Objectives: Results of recent years inclicate that CMV may play important
role in etiopathogenesis of arteriosclerosis. Our studies aimed at evaluation
oflipid metabolism exponents (cholesterol and its fractions; triglycerides) in
active CMV infection in children.
Methods: The stuclies were performed on 45 hospitalised children. aging 5
to 15 years, in whom active CMV infection. primary or secondary, was
diagnosed on the basis of the presence of serum anti-CMV antibodies
(VIDAS CMV IgM, VIDAS CMV IgG; bioMerieux) and ofCMV DNA
(Sharp Signal System; Digene). Serum triglycerides, total cholesterol, HDL-
cholesterol and LDL-cholesterol levels were determined by means of the
automatic Reflotron tests and the Reflotron IV analyser (Boehringer
Mannheim).
Results: In children with primary active CMV infection, mean values of
serum lipid proftle were as follows: total cholesterol 142 ± 32.9 mg/dl;
HDL-cholesterol23.4 ± 8.6 mg/dl; LDL-cholesteroI97.8 ± 30.9 mg/dl;
triglycerides 83 ± 15.5 mg/dl. In children with secondary active CMV
infection the mean values of serum lipid profile were as follows: total
cholesterol 142.5 ± 44.2 mg/dl; HDL-cholesteroI21.4 ± 10.8 mg/dl; LDL-
cholesterol 87.1 ± 35.3 mg/dl; triglycerides 101.7 ± 31.2 mg/dl. In both
grups of examined children only HDL-cholesterolleve1s were significantly
lowered, as compared to recommended values (p < 0.05) while the
remaning parameters showed no deviations from the values (p > 0.05).
Conclusions: Active infection with CMV is accompanied by clisturbed
HDL-cholesterolleveIs in serum.
IMoP70IEpstein-Barr VIrus (EBV) Infection in patients with
Palatine Tonsil carcinoma (PrO
A. Szkaradkiewicz, A. Kruk-Zagajewska, A. jopek, M. Wierzbicka
Karol Marcinkowski University ofMedical Sciences in Poznan, Poland
Objectives: Causal link of EBV and endemically manifesting nasopharyn-
geal carcinoma has already been well documented. Our study aimed at
examining whether EBV infection occurs also in patients with another
tumor, PTC, in Poland.
Methods: The studies were performed on 20 patients, aged 40 to 65 years, in
whum PTC was diagnosed by histological methods. Sera of the patient.
were tested for EBV DNA (Sharp Signal System; Digene), IgM-anti-EBV
antiboclies (Behring), IgG-anti-EA antibodies (ETI-EA-G; DiaSorin) and
IgG-anti-VCA antiboclies (ETl-VCA-G; DiaSorin).
Results: Serological exponents of reactivated EBV infection (serum IgG-
anti-EA and IgG-anti-VCA antiboclies) were detected in 12 patients. In
